T.C. SAĞLIK BAKANLIĞI İzmir İl Sağlık Müdürlüğü S.B.Ü. Dr. Behçet Uz Çocuk Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi

T.C. SAĞLIK BAKANLIĞI İzmir İl Sağlık Müdürlüğü S.B.Ü. Dr. Behçet Uz Çocuk Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi

Facebook Twitter Google Plus Linkedin

Doç. Dr. Raziye Canan Vergin

Güncelleme Tarihi: 01/02/2019

A.      KİŞİSEL BİLGİLER

Adı Soyadı: Raziye Canan  VERGİN

Doğum tarihi: 1953

Yabancı dil bilgisi: İngilizce

Görev yeri: Dr. Behçet Uz Çocuk Hastalıkları ve Cerrahisi EAH, Hematoloji-Onkoloji Kliniği

B.      EĞİTİM BİLGİLERİ

Mezun olduğu üniversite/fakülte:Ege Üniversitesi Tıp Fakültesi

Mezuniyet tarihi:1977

Akademik ünvanı: Doçent Doktor

C.      İŞ TECRÜBESİNE AİT BİLGİLER

Bugüne kadar çalıştığı kurum/kuruluşlar:

Tıpta uzmanlık öğrenciliği:1978-1982 Ege Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı

Uzmanlık sonrası mecburi hizmet:1983-1986 Bilecik Devlet Hastanesi

Başasistanlık:1987-1991 Dr. Behçet Uz Çocuk Hastalıkları Araştırma ve Eğitim Hastanesi
Yan Dal Uzmanlık Eğitimi:1992-1994 Ege Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı, Hematoloji Bilim Dalı

Şef yardımcılığı:1992-2000 Dr. Behçet Uz Çocuk Hastalıkları Araştırma ve Eğitim Hastanesi
Hematoloji Kliniği Eğitim Görevlisi: 2000- Dr. Behçet Uz Çocuk Hastalıkları Araştırma ve Eğitim Hastanesi

D.      KLİNİK ARAŞTIRMALARLA İLGİLİ GENEL BİLGİLER

A.1. Çetingül N, Vergin C, Kavaklı K, Öztop S, Levent E: Kasabach-Merritt Syndrome in a  neonate. J Neonatol. 1994; 1(3): 29-32.

A.2. Nişli G., Çetingül N., Vergin C, Kavaklı K., Tercan F: Idiopathic hypereosinophilic syndrom in neonatal period. J  Neonatol. 1994; 1(4): 21-24.

A.3. Çetingül N, Kavaklı K, Vergin C, Öztop S, Nişli G, Özacar T, Bilgiç A: Hepatitis B, hepatitis C and HIV markers in pediatric malignancies. Turk J Cancer. 1994, 24 (4): 175-180.

A.4. Vergin C, Çetingül N, Kavaklı K, Öztop S, Köprübaşı F, Çoker M, Nişli G, Soydan S, Balık E: A patient with WT syndrome + Castleman disease. Acta Pediatr Japon 1995; 3 (1): 108-112.

A.5. Çetingül N, Vergin C, Kurugöl Z, Yener E, Kavaklı K, Nişli G, Öztop S: Pedigrees of                                                                                                                                                                                    patients with malignancy. Indian J Pediatr 1995; 62: 503-504.

A.6. Vergin C, Çetingül N, Kavaklı K, Özkınay F, Darcan Ş, Öztop S, Nişli G, Balık E, Erhan Y: Granulosa cell tumor in childhood: a case report. Turk J Cancer. 1995; 25(1): 57-61.

A.7. Nisli G, Kavakli K, Vergin C, Öztop S, Çetingül N.: Recombinant human erythropoietin trial in thalassemia intermedia. Journal Of Tropıcal Pedıatrıcs  1996; 42 (6): 330-334   
A.8. Cetingul N, Kavakli K, Vergin C, Öztop S, Nişli G, Aydoğdu S, Özacar T, Bilgiç A,                                                                                                                                                                                      Yüce G, Yağcı R.:Alpha-interferon-2b treatment for chronic hepatitis-B infection in children with cancer. Journal Of Tropıcal Pedıatrıcs 1996; 42(5):262-266   
A.9. Kutukculer N, Vergin C, Cetingul N, et al.; Plasma interleukin-3 (IL-3) and IL-7 concentrations in children with homozygous beta-thalassemia. Journal Of Tropıcal Pedıatrıcs1997;43 (6):366-367   

A.10. Kutukculer N, Vergin C, Kavakli K, et al.: Specific antibody response in children with thalassemia major. Pedıatrıc Hematology And Oncology  1997; 14(2): 181-183

A.11.Vergin C, Kütükçüler N, Çetingül N, Nişli G, Çağlayan S, Öztop S: Serum immunoglobulins, IgG subclasses, isoaglutinins and complement-3 levels in patients with thalassemia major. Indian J Pediatr 1997; 64(2): 215-219

A.12. Atlıhan F, Serdaroğlu G, Targan Ş, Uran N, Vergin C, Çalkavur Ş: Neurotoxicity following treatment with methotrexate: a report of two cases. Turk J Cancer 1997; 27(2): 78-83.

A.13. Öztop S, Çetingül N, Yener E, Kavaklı, Vergin C, Tercan F, Nişli G: Treatment strategy, progress and problems with childhood ALL: 12 year of eperience at Ege University. Turk J Cancer 1997; 27(2): 66-73.

A.14. Vergin C, Kütükçüler N, Kavaklı K, Çetingül N, Öztop S, Nişli G, Çağlayan S: Beta thalassemia major: Plasma cytokine (IL-3, IL-7) concentrations regulating immune response and erythropoiesis. Turk J Haematol 1997; 14: 97-100

A.15. Kütükçüler N, Vergin C, Çetingül N, Nişli G, Kurugöl Z, Öztop S, Çağlayan S: The assessment of cell-mediated immunity and plasma IL-2 conventrations in children with thalassemia major. Turk J Immunol 1997; 2: 11-16

A.16. Serdaroğlu G, Serdaroğlu E, Arslanoğlu S, Ortaç R, Umutlu N, Kayserili E, Gülez P, Vergin C: Veno-occlusive disease of the liver after chemotherapy for acute lymphoblastic leukemia: a case report. Turk J Cancer 1999; 29(3): 136-140

A.17.  Düzovalı Ö, Ortaç R, Karaca İ, Argon N, Uslu Y, Anacak Y, Vergin C, Atlıhan F: Childhood cancer survival 1990-1997: Dr Behçet Uz Children’s Hospital registry. Turk J Cancer 2000; 30(2): 68-74

A.18. Gulesken S, Oren H, Vergin C, Sanlı N, Gulen H,. Ucar C, İrken G: Mutational analysis of beta-thalassemia cases from the Aegean region of Turkey using an allele-specific oligonucleotide hybridization techniqueActa Haematologıca   2000; 104 (4):181-184 
A.19. Ortaç R, Aktaş S, Diniz G, Erbay A, Vergin C: Prognostic role of natural killer cells in pediatric mixed cellularity and nodular sclerosing Hodgkin's disease.Anal Quant Cytol Histol. 2002 Oct;24(5):249-53.

A.20. Apa H, Diniz G, Sarıtaş T, Aktaş S, Ortaç R, Karaca İ, Karkıran A, Vergin C: Abdominal inflamatory myofibroblastic tumor: Review of the literature by means of a case report. Turk J Cancer, 2002; 32(1): 28-31.

A.21.Aksu G, Kütükçüler N, Genel F, Vergin C, Omowaire B: Griscelli syndrome without hemophagocytosis in an eleven-year-old girl: expanding the phenotypic spectrum of Rab27A mutations in humans.Am J Med Genet  2003 Feb 1;116A(4):329-33.

A.22.Olgun N, Kansoy S, Aksoylar S, Cetingul N, Vergin C, Oniz H, Sarialioglu F, Kantar M, Uysal K, Tuncyurek M, Kargi A, Aktas S, Bayol U, Karaca İ, Arikan A, Balik E, Aktug T, Elmas N, Kovanlikaya A, Kinay M, Anacak Y, Degirmenci B, Burak Z: Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol.Pediatr Hematol Oncol 2003 Apr-May;20(3):211-8.

A.23.  Aktaş S, Ortaç R, Diniz G, Erbay A, Vergin C: Prognostic role of natural killer cells in pediatric non-Hodgkin’s lymphoma. Turk J Cancer 2003; 33(2): 91-95

A.24. Diniz G, Aktaş S, Ortaç R, Unlü I, Vergin C. A comparative immunohistochemical study of HBsAg, HBcAg and CD57 in chronic hepatitis B pediatric patients with and without malignant disorders.Turk J Gastroenterol 2003 Dec;14(4):234-8.

A.25. Aktaş S, Apa H, Diniz G, Erbay A, Ortaç R, Vergin C, Karaca İ, Elmas N, Yüzer Y. Androgen related hepatocellular tumor of the liver associated with Fanconi’s anemia. Turk J Cancer 2003; 33(1): 51-54

A.26.Ozdemir D, Kayserili E, Arslanoglu S, Gulez P, Vergin C: Ketamine and midazolam for invasive procedures in children with malignancy: a comparison of routes of intravenous, oral, and rectal administration.J Trop Pediatr 2004 Aug;50(4):224-8.

A.27.Oren H, Devecioğlu O, Ertem M, Vergin C, Kavakli K, Meral A, Canatan D, Toksoy H, Yildiz I, Kürekç i E, Ozgen U, Oniz H, Gürgey A. Analysis of pediatric thrombotic patients in Turkey.Pediatr Hematol Oncol 2004 Oct-Nov;21(7):573-83.

A.28. Genel F, Cevik A, Erbay A, Gulen H, Uran N, Vergin C: Acute T-cell lymphoblastic leukaemia as a presenting finding of ataxia-telangiectasiaAnnals Of Tropıcal Paedıatrıcs  2004; 24(2):193-194   

A.29. Aktaş S, Diniz G, Ortaç R, Erbay A, Vergin C: Role of nm23 expression in neuroblastoma determining prognosis and metastatic potencial. Turk J Cancer 2004; 34(3), 101-105

A.30. Cogulu O, Kosova B, Karaca E, Gunduz C, Ozkinay F, Aksoylar S, Gulen H, Kantar M, Oniz H, Karapinar D, Cetingul N, Erbay A, Vergin C, Ozkinay C. Evaluation of telomerase mRNA (hTERT) in childhood acute leukemia.Leuk Lymphoma 2004 Dec;45(12):2477-80.

A.31. Diniz G, Aktaş S, Ortaç R, Erbay A, Vergin C, Ergin M: Alternative prognostic factors in pediatric embryonal rhabdomyosarcoma: Nm23 expression, proliferative activity and angiogenesis.Turk J Pediatr. 2004 Jul-Sep;46(3):239-44

A.32. Gulen H, Erbay A, Gulen F, Kazancı E, Demir E, Tanaç R, Vergin C: Resistant pneumonia in a child with Non-Hodgkin’s lymphoma in remission: A case of M. Tuberculosis. Inter J of Hematol 2005; 2(1).

A.33. Gulen H, Kazancı E, Özek DG, Erbay A, Yamacı S, Aktaş S, Vergin C: Calcinosis cutis in a patient with Burkitt lymphoma. Turk J Haematol 2005; 22(3): 151-154

A.34.Gülen H, Tüzün F, Ayhan Y, Erbay A, Oztürk E, Inan S, Vergin C: The evaluation of blood donor deferral causes.Pediatr Hematol Oncol 2006 Mar;23(2):91-4.

A.35. Diniz G, Aktas S, Ortac R, Tunakan M, Unlu I, Vergin C: Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.Pathol Res Pract 2006;202(9):671-7.

A.36. Gulen H, Erbay A, Gülen F, Kazancı E, Vergin C, Demir E, Tanaç R: Sinopulmonary aspergillosis in children with hematological malignancy. Minerva Pediatr 2006; 58(3): 319-324

A.37. Gülen H, Erbay A, Kazancı E, Vergin C: A rare familial thrombocytopenia: May-Hegglin anomaly report of two cases and review of the literature. Turk J Hematol 2006; 23: 111-114

A.38. İrken G, Ören H, Öniz H, Çetingül N, Vergin C, Atabay B, Gülen H, Türker M, Kantar M, Yılmaz Ş: Hyperleukocytosis in childhood lymphoblastic leukemia: complications and treatment outcome. Turk J Hematol 2006; 23: 142-146

A.39. Aktaş S, Kargi A, Olgun N, Diniz G, Erbay A, Vergin C: Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma.Lymphat Res Biol 2007;5(3):175-82.

A.40. Gulen H, Kazancı E, Meşe T, Uzunkaya D, Erbay A, Tavlı V, Vergin C: Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukemia. Minerva Pediatr 2007; 59: 107-113

A.41- Aktaş S, Kargı A, Olgun N, Diniz G, Erbay A, Vergin C: Prognostic significance of cyclooxygenase-2 expression in pediatric Hodgkin and non-Hodgkin lymphomas with or without Epstein-Barr virus latent infection. Comparative Clinical Pathology 2008; 17(2): 125-131  

A.42. Cogulu O, Kosova B, Gunduz C, Karaca E, Aksoylar S, Erbay A, Karapinar D, Vergin C, Vural F, Tombuloglu M, Cetingul N, Ozkinay F: The evaluation of hTERT mRNA expression in acute leukemia children and 2 years follow-up of 40 cases.Int J Hematol 2008; 87(3): 276-83.

A.43.Aktaş S, Kargı A, Olgun N, Diniz G, Erbay A, Vergin C: Prognostic Significance of Cell Proliferation and Apoptosis-Regulating Proteins in Epstein-Barr Virus Positive and Negative Pediatric Non-Hodgkin's Lymphoma.Pathol Oncol Res  2008 Dec 2.

A.44. Ertan Y, Sezak M, Turhan T, Kantar M, Erşahin Y, Mutluer S, Vergin C, Oniz H, Akalin T. Atypical teratoid/rhabdoid tumor of the central nervous system: clinicopathologic and immunohistochemical features of four cases. Childs Nerv Syst. 2009 Jun;25(6):707-11.

A.45. Ferah Genel, Füsun Atlıhan, Nesrin Gülez, Elif Kazancı, Canan Vergin, Demet Tümay Terek. Evaluation of adesion molecules CD64, CD11b and CD62L in neutrophils and monocytes of peripheral blood for early diagnosis of neonatal infection. World J Pediatr, 2012 Feb;8(1):72-5.

A.46. Diniz G, Aktas S, Turedi A, Temir G, Ortac R, Vergin C: Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor.Tumour Biol. 2011 Aug;32(4):761-7. Epub 2011 May 8

A.47. Oymak Y, Dodurga Y, Turedi A, Yaman Y, Ozek G, Carti O, Gunes BT, Erbudak E, Berber E, Avci CB, Vergin C. Higher expression of the novel gene upregulated gene 4 in two acute lymphoblastic leukemia patients with poor prednisolone response.Acta Haematol. 2012;128(2):73-6.

A.48. Aydinok Y, Unal S, Oymak Y, Vergin C, Türker ZD, Yildiz D, Yesilipek A. Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload. Eur J Haematol. 2012 May;88(5):431-8.

A.49. Dınız G, Genel F, Yücel N, Türedı A, Vergın C. A case of CD20 positive mediastinal rhabdomyosarcoma Turk Patoloji Derg. 2012;28(3):270-3

A.50. Aydan Çankal, Özlem Tüfekçi, Salih Gözmen, Faize Yüksel, Canan Vergin, Gülersu İrken, Hale Ören. The evaluation of protein Z levels of children with acute lymphoblastic leukemia during induction therapy. Blood Coagulation & Fibrinolysis. June 2013; 24 (4): 375-380

A.51. Yavuz Dodurga, Yeşim Oymak, Cumhur Gündüz, N Lale Satıroğlu Tufan, Canan Vergin, Nazan Çetingül, Çığır Biray Avcı, Nejat Topçuoğlu. Leukomogenesis as a new approach to investigate to correlation between up regulated gene 4/upregulator of cell proliferation (URG4/URGCP) and signal transduction genes in leukemia. Molecular Biology Reports. April 2013; 40 (4): 3043-3048

A.52. Gülden Diniz, Safiye Aktaş, Cankut Çubuk, Ragıp Ortaç, Canan Vergin, Nur Olgun. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases. Pediatric Hematology and Oncology. May 2013; 30 (4): 273-284.

A.53. Ali Orgun, Şebnem Çalkavur, Özgür Olukman, Leman Tekin, Fatma Kaya Kılıç, Yüce Ayhan, Canan Vergin, Füsun Atlıhan. Role of minor erythrocyte antigens on alloimmunuzation in neonatal indirect hyperbilirubinemia backround. Turk Arch Ped 2013; 48: 23-29

A.54. Turedi A, Oymak Y, Meşe T, Yaman Y, Bayraktaroglu S, Alpman A, Ozkinay F, Aydınok Y, Vergin C.  The Effect of HFE Polymorphisms on Cardiac Iron Overload in Patients with Beta-Thalassemia Major. Pediatr Hematol Oncol. 2013 Nov;30(8):755-60.

A.55. Zeytinoglu M, Aykut A, Hazan F, Torrente I, Akay MC, Karapinar DY, Vergin C, Cogulu O, Ozkinay F. A novel mutation, IVS13+5G>A, in Ellis-van Creveld syndrome associated with haemophagocytic lymphohistiocytosis. Clin Dysmorphol. 2013 Aug 6.

A.56. Yöntem Y, Ilker D, Yeşim O, Ayşen T, Gülcihan O, Özgür C, Meral AC, Burçak TG, Bengü D, Esin A, Selim B, Canan V. Analysis of fatal cases of pandemic influenza A (H1N1) virus infections in pediatric patients with leukemia. Pediatr Hematol Oncol. 2013 Aug;30(5):437-44.

A.57. Ergin H, Ozdemir OM, Karaca A, Türk NS, Düzcan F, Ergin S, Kazancı E, Vergin C, Erbay A. A Newborn with Congenital Mixed Phenotype Acute Leukemia After In Vitro Fertilization. Pediatr Neonatol. 2013 Apr 29.

A.58. Duyu M, Durmaz B, Gunduz C, Vergin C, Yilmaz Karapinar D, Aksoylar S, Kavakli K, Cetingul N, Irken G, Yaman Y, Ozkinay F, Cogulu O. Prospective Evaluation of Whole Genome MicroRNA Expression Profiling in Childhood Acute Lymphoblastic Leukemia.Biomed Res Int. 2014;May 14.

A.59. Gözmen S, Karapnar TH, Tüfekçi O, Vergin C, Yüksel F, Irken G, Oren H.B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood.Blood Coagul Fibrinolysis. 2014 Jun 6

A.60. Karapnar TH, Karadaş N, Ozek G, Tüfekçi O, Atabay B, Türker M, Yüksel F, Karapnar DY, Vergin C, Irken G, Oren H.The investigation of relationship between joint findings and serum angiogenic and inflammatory factor levels in severe hemophilia A patients.Blood Coagul Fibrinolysis. 2014 May 20.

A.61. Devrim I, Yaman Y, Demirağ B, Oymak Y, Cartı O, Ozek G, Tulumoğlu S, Erdem T, Gamze G, Gözmen S, Tatlı Güneş B, Bayram N, Vergin C.A Single Center's Experience with Candida parapsilosis Related Long-Term Central Venous Access Device Infections: The Port Removal Decision and Its Outcomes.Pediatr Hematol Oncol. 2014 Jan 2.    

A.62. Yldrm AT, Güneş BT, Oymak Y, Yaman Y, Ozek G, Cart O, Yeşilipek A, Vergin C.Congenital amegakaryocytic thrombocytopenia: three case reports from patients with different clinical diagnoses and somatic abnormalities.Blood Coagul Fibrinolysis. 2014 Sep 3.

A.63. Aykut A, Onay H, Durmaz A, Karaca E, Vergin C, Aydınok Y, Ozkınay F. Molecular analysis of abnormal hemoglobins in beta chain in Aegean region of Turkey and first reports of hemoglobin Andrew-Minneapolis and Hb Hinsdale from Turkey. Hematology.  2015 Jul;20(6):354-8.14.

A.64.    Ozkinay F, Onay H, Karaca E, Arslan E, Erturk B, Ece Solmaz A, Tekin IM, Cogulu O, Aydinok Y, Vergin C. Molecular Basis of β-Thalassemia in the Population of the Aegean Region of Turkey: Identification of A Novel Deletion Mutation. Hemoglobin. 2015 Jun 15:1-5.

A.65. Onay H, Aykut A, Karaca E, Durmaz A, Solmaz AE, Çoğulu Ö, Aydınok Y, Vergin C, Özkınay F. Molecular spectrum of α-globin gene mutations in the Aegean region of Turkey: first observation of three α-globin gene mutations in the Turkish population. Int J Hematol. 2015 Jul;102(1):1-6.

A.66. Afsar FS, Ozek G, Vergin C. Half-and-half nails in a pediatric patient after chemotherapy. Cutan Ocul Toxicol. 2015 Jan 19:1-2.

A.67. Ince D, Demirag B, Karapinar T, Oymak Y, Ay Y, Kaygusuz A, Toret E, Vergin C. Assessment of Sleep in Pediatric Cancer Patients and Survivors. Sylwan. 2015; 159(5):116-138.

A.68. Y. Oymak, Y. Ayhan, T.H. Karapinar, I Devrim, Y. Ay, H. Sarihan, C. Vergin. Granulocyte transfusion experience in pediatric neutropenic fever: Splitted product can be an alternative?Transfus Apher Sci. 2015; 20. pii: S1473-0502(15)00135-4. doi: 10.1016/j.transci.2015.07.002

A.69. Y. Oymak, A. Kaygusuz, A. Turedi Yildirim, Y. Yaman, E. Eser, D. Cubukcu, C. Vergin. Comparing the Quality of Life of Patients With Hemophilia and Juvenile Idiopatic Arthiritis in Which Chronic Arthropathy is a common Complication. J Pediatr Hematol Oncol 2015; 000-000. Doi:10.1097/MPH.0000000000000429

A.70. Devrim İ1, Demirağ B, Yaman Y, Bayram N, Özdemir F, Kara A, Özek G, Ayhan Y, Gülfidan G, Oymak Y, Vergin C. A 7-year study of the distribution of nosocomial candidemia in children with cancer. Turk J Pediatr.2015 May-Jun;57(3):225-9.

A.71. Devrim F1Gülfidan GGözmen SDemirağ BOymak YYaman YOruç Y,Yaşar NApa HBayram NVergin CDevrim İ. Comparison of the BD GeneOhm VanR assay and a chromogenic agar-based culture method in screening for vancomycin-resistant enterococci in rectal specimens of pediatric hematology-oncology patients.Turk J Pediatr. 2015 Mar-Apr;57(2):161-6.

A.72. Ay Y1, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura. Blood Coagul Fibrinolysis.2015 Dec 11. [Epub ahead of print]

A.73. Karapınar TH, Oymak Y, Ay Y, Köker SA, Töret E, Hazan F, Vergin C. Chronic Neutropenia in Childhood: Experience From a Single Center. J Pediatr Hematol Oncol. 2016 Jan;38(1):e35-8. (SCI YAYIN)

A.74. Ay Y, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura. Blood Coagul Fibrinolysis. 2016 Jun;27(4):431-5. (SCI YAYIN)

A.75. Olukman O1, Özdemir R, Karadeniz C, Calkavur S, Mese T, Vergin C. Is there a relationship between platelet parameters and patency of ductus arteriosus in preterm infants? Blood Coagul Fibrinolysis. 2016 Jan 28. [Epub ahead of print]

A.76. Onur Doyurgan, Uğur Karagöz, Bengü Demirağ, Mustafa Karaçelik, Yılmaz Ay, Raziye Canan Vergin, Osman Nejat SarıosmanoğluUse of Subcutaneous Port Catheter in Childhood Malignancies. World Journal of Cardiovascular Diseases 2016 Vol.6 No.5.

A.77. Aksoylar S, Varan A, Vergin C, Hazar V, Akici F, Dagdemir A, Buyukavci M, Kebudi R, Kurucu N, Sevinir B, Unal E, Vural S, Guler E, Apak H, Oniz H, Karadeniz C, Canpolat C, Anak S, Ilhan I, Ince D, Cecen E, Olgun N. Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group. J Cancer Res Ther. 2017 Apr-Jun;13(2):284-290. doi: 10.4103/0973-1482.183205.

A.78. Katipoğlu N, Karapinar TH, Demir K, Aydin Köker S, Nalbantoğlu Ö, Ay Y, Korkmaz HA, Oymak Y, Yıldız M, Tunç S, Hazan F, Vergin C, Ozkan B. Infantile-onset thiamine responsive megaloblastic anemia syndrome with SLC19A2 mutation: a case report. Arch Argent Pediatr. 2017 Jun 1;115(3):e153-e156. doi: 10.5546/aap.2017.eng.e153. English, Spanish.

A.79. Aydınok Y, Oymak Y, Atabay B, Aydoğan G, Yeşilipek A, Ünal S, Kılınç Y, Oflaz B, Akın M, Vergin C, Sezgin Evim M, Çalışkan Ü, Ünal Ş, Bay A, Kazancı E, İleri DT, Atay D, Patıroğlu T, Kahraman S, Söker M, Akcan M, Akdeniz A, Büyükavcı M, Alanoğlu G, Bör Ö, Soyer N, Özdemir Karadaş N, Uysalol E, Türker M, Akçay A, Ocak S, Güneş AM, Tokgöz H, Uysal Z, Tiftik N, Karakaş Z. A national registry of thalassemia in Turkey; demographic and disease characteristics of patients, achievements and challenges in prevention. Turk J Haematol. 2017 Apr 13. doi: 10.4274/tjh.2017.0039. [Epub ahead of print]

A.80. Tüfekçi Ö, Koçak Ü, Kaya Z, Yenicesu İ, Albayrak C, Albayrak D, Yılmaz Bengoa Ş, Patıroğlu T, Karakükçü M, Ünal E, Ünal İnce E, İleri T, Ertem M, Celkan T, Özdemir GN, Sarper N, Kaçar D, Yaralı N, Özbek NY, Küpesiz A, Karapınar T, Vergin C, Çalışkan Ü, Tokgöz H, Sezgin Evim M, Baytan B, Güneş AM, Yılmaz Karapınar D, Karaman S, Uygun V, Karasu G, Yeşilipek MA, Koç A, Erduran E, Atabay B, Öniz H, Ören H. Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of 65 Patients. Turk J Haematol. 2017 Feb 9. doi: 10.4274/tjh.2017.0021. [Epub ahead of print]

A.81. Karapınar TH, Yılmaz Karapinar D, Oymak Y, Ay Y, Demirağ B, Aykut A, Onay H, Hazan F, Aydınok Y, Özkınay F, Vergin C. HAX1 mutation positive children presenting with haemophagocytic lymphohistiocytosis. Br J Haematol. 2017 May;177(4):597-600. doi: 10.1111/bjh.14574. Epub 2017 Feb 7.

A.82. Koker SA1, Gözmen S1, Oymak Y1, Karapinar TH1, Can D2, Genç S3, Vergin RC1. Idiopathic Pulmonary Hemosiderosis Mimicking Iron Deficiency Anemia: A Delayed Diagnosis? Hematol Rep. 2017 Jun 15;9(2):7048. doi: 10.4081/hr.2017.7048. eCollection 2017 Jun

A.83. Afsar FS1Ergin M2Ozek G2Vergin C2Karakuzu A3Seremet S1. LATE-ONSET SELF-HEALING LANGERHANS CELL HISTIOCYTOSIS: REPORT OF A VERY RARE ENTITY.Rev Paul Pediatr. 2017 Jan-Mar;35(1):115-119.

A.84. Olukman, Ozgur; Ozdemir, Rahmi; Karadeniz, Cem; Calkavur, Sebnem; Mese, Timur; Vergin, Canan. s there a relationship between platelet parameters and patency of ductus arteriosus in preterm infants? Blood Coagulation & Fibrinolysis: January 2017 - Volume 28 - Issue 1 - p 8–13

A.85.-İnce D, Demirağ B, Karapınar TH, Oymak Y, Ay Y, Kaygusuz A, Töret E, Vergin C. Assessment of sleep in pediatric cancer patients. Turk J Pediatr. 2017;59(4):379-386.

A.86. Tüfekçi Ö, Koçak Ü, Kaya Z, Yenicesu İ, Albayrak C, Albayrak D, Yılmaz Bengoa Ş, Patıroğlu T, Karakükçü M, Ünal E, Ünal İnce E, İleri T, Ertem M, Celkan T, Özdemir GN, Sarper N, Kaçar D, Yaralı N, Özbek NY, Küpesiz A, Karapınar T, Vergin C, Çalışkan Ü, Tokgöz H, Sezgin Evim M, Baytan B, Güneş AM, Yılmaz Karapınar D, Karaman S, Uygun V, Karasu G, Yeşilipek MA, Koç A, Erduran E, Atabay B, Öniz H, Ören H. Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients. Turk J Haematol. 2018 Mar 1;35(1):27-34.

A.87. Yeşim Aydınok, Yeşim Oymak, Berna Atabay, Gönül Aydoğan, Akif Yeşilipek, Selma Ünal, Yurdanur Kılınç, Banu Oflaz, Mehmet Akın, Canan Vergin, Melike Sezgin Evim, Ümran Çalışkan, Şule Ünal, Ali Bay, Elif Kazancı, Talia İleri, Didem Atay, Türkan Patıroğlu, Selda Kahraman, Murat Söker, Mediha Akcan, Aydan Akdeniz, Mustafa Büyükavcı, Güçhan Alanoğlu, Özcan Bör, Nur Soyer, Nihal Özdemir Karadaş, Ezgi Uysalol, Meral Türker, Arzu Akçay, Süheyla Ocak, Adalet Meral Güneş, Hüseyin Tokgöz, Elif Ünal, Naci Tiftik, Zeynep Karakaş A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention Turk J Haematol. 2018 Mar; 35(1): 12–18. 

A.88. Devrim İ, Oruç Y, Demirağ B, Kara A, Düzgöl M, Uslu S, Yaşar N, Aydın Köker S, Töret E, Bayram N, Vergin C. Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients.J Vasc Access. 2018 Jul;19(4):358-365.

A.89. Antmen BKarakaş ZYeşilipek MAKüpesiz OAŞaşmaz İUygun VKurtoğlu EOktay GAydogan GAkın MSalcioglu ZVergin CKazancı EGÜnal SÇalışkan ÜAral YZTürkkan EMeral Güneş ATunç BGümrük FAyhan ACSöker MKoç AOymak YErtem MTimur ÇYıldırmak Yİrken GApak HBiner BEren TGIşık Balcı YKoçak ÜKarasu GAkkaynak DPatıroğlu T. Deferasirox in children with transfusion-dependent thalassemia or sickle cell anemia: A large cohort real-life experience from Turkey (REACH-THEM). Eur J Haematol. 2018 Oct 9. doi: 10.1111/ejh.13180. [Epub ahead of print]

A.90. Yaman YDevrim İOzek G3Demirağ BOymak YGülfidan GVergin C. Non-typhoidal Salmonella bacteraemia in paediatric leukaemia patients.Contemp Oncol (Pozn). 2018;22(2):105-107. doi: 10.5114/wo.2018.76446. Epub 2018 Jun 14. (SCI-E YAYIN)

A.91. Burcu ANazan ÇÖzgür ÖSerra KMehmet KSerap ABengü DCanan VHaldun Ö6Savaş KTuncer TTaner AYeşim EÖmer KYavuz A. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?Childs Nerv Syst. 2018 Sep;34(9):1657-1662. doi: 10.1007/s00381-018-3842-6. Epub 2018 Jun 4.

A.92. Toret EDemirag BKöker SADoyurgan OErgin MGenc SKarapinar THAy YOymak YVergin C. Aplastic Anemia as an Immune-mediated Complication of Thymoma: A Case Report. J Pediatr Hematol Oncol. 2018 Oct;40(7):e464-e466. doi: 10.1097/MPH.0000000000001140.

A.93. Aydin Koker S, Karapinar TH, Oymak Y, Bianchi P, Fermo E, Gozmen S, Vergin C. Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia. J Pediatr Hematol Oncol. 2018 Oct;40(7):e421-e423.